Evolving Definitions of Remission in Crohn’s Disease
- 1 July 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 19 (8) , 1645-1653
Abstract
Background. Using clinical symptoms alone to inform treatment decisions in Crohn’s disease (CD) may increase the risk of disease progression and complications.Keywords
This publication has 23 references indexed in Scilit:
- Mucosal Healing in Crohnʼs DiseaseInflammatory Bowel Diseases, 2013
- Development of the Paris Definition of Early Crohn's Disease for Disease-Modification Trials: Results of an International Expert Opinion ProcessAmerican Journal of Gastroenterology, 2012
- Magnetic resonance imaging for evaluation of Crohnʼs diseaseInflammatory Bowel Diseases, 2011
- Development of the Crohnʼs disease digestive damage score, the Lémann scoreInflammatory Bowel Diseases, 2011
- Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial DataAmerican Journal of Gastroenterology, 2010
- The Natural History of Adult Crohn's Disease in Population-Based CohortsAmerican Journal of Gastroenterology, 2010
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trialThe Lancet, 2009
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs diseaseInflammatory Bowel Diseases, 2009
- Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosisCochrane Database of Systematic Reviews, 2008
- Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's diseaseGastrointestinal Endoscopy, 2006